Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

5.32
-0.5900-9.98%
Post-market: 5.13-0.1894-3.56%19:59 EDT
Volume:60.53M
Turnover:340.61M
Market Cap:2.31B
PE:-2.95
High:6.20
Open:6.04
Low:5.30
Close:5.91
52wk High:12.36
52wk Low:3.79
Shares:434.15M
Float Shares:415.00M
Volume Ratio:1.15
T/O Rate:14.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8042
EPS(LYR):-1.6909
ROE:-86.34%
ROA:-39.08%
PB:2.51
PE(LYR):-3.15

Loading ...

Jun 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2023

Major Issues Report

Form 8-K - Current report
Jun 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
Jun 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 31, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 26, 2023

Major Issues Report

Form 8-K - Current report
May 23, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 18, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 17, 2023

Major Issues Report

Form 8-K - Current report
May 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 08, 2023

Major Issues Report

8-K - Current report
May 08, 2023

Major Issues Report

8-K - Current report
May 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]